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cense.Abstract Introduction: Nailfold capillaroscopy is a non-invasive technique to recognize peripheral
microangiopathy, which is an important feature in SLE.
Aim of the work: To study the prevalence of nailfold capillaroscopy (NFC) changes in patients with
systemic lupus erythematosus (SLE), ﬁnd out the patterns of these changes and to correlate these
ﬁndings with different clinical and laboratory parameters.
Patients and methods: Forty patients with SLE, all fulﬁlling the 1997 revised criteria for the classiﬁ-
cation of SLE were included. All patients included in this study were subjected to full history taking,
clinical examination, laboratory investigations as well as nailfold capillaroscopy (NFC) examination.
Results: The prevalence of nailfold capilloroscopic (NFC) changes in SLE patients was 75%. Nail-
fold capillaroscopic abnormalities were signiﬁcantly more frequent in SLE patients than in controls
(P< 0.05). Different abnormalNFC changes were seen with themeandering patternmore frequently
seen. The afferent and efferent capillary loops diameters were signiﬁcantly increased in the SLE
patients than in the control group (P< 0.05). Some of the NFC abnormalities showed statistical sig-
niﬁcant correlations with different clinical and laboratoryparameters. Capillary loop afferent andopy; RP, Raynaud’s phenom-
us; SLEDAI, Systemic Lupus
ESR, erythrocyte sedimenta-
ANA, antinuclear antibodies;
meter.
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62 O. Ragab et al.efferent diameters were signiﬁcantly correlated with disease duration (P< 0.05) as well as the occur-
rence of digital gangrene (P< 0.05). Also the capillary loop afferent diameter was found to be corre-
lated with the intake of cyclophosphamide (P< 0.05).
Conclusion: Signiﬁcant microcirculatory changes occur in systemic lupus erythematosus (SLE)
patients as proved by the high prevalence of capillary abnormalities in lupus patients compared to con-
trols by means of nailfold capillaroscopy. Some nailfold capillaroscopy changes e.g. meandering cap-
illaries may complete picture of SLE diagnosis. Duration of SLE disease may have an impact on
microcirculation of these patients. The presence of some nailfold capillaroscopy changes in SLE
patients may be an alarming sign to fatal ischemia of the digits.
 2011 Egyptian Society for Joint Diseases and Arthritis. Production and hosting by Elsevier B.V.
Open access under CC BY-NC-ND license.1. Introduction
Nailfold capillaroscopy (NFC) is a non-invasive and safe tech-
nique used to recognize peripheral microangiopathy and it is
also reported to have both diagnostic and prognostic value [1].
Microvascular involvement is an important feature in SLE [2].
NFC may be a useful method to evaluate the microvascular
changes in patients with SLE [3], and it was proved to be an
easy-to-perform, able to achieve useful data that evaluates better
such a pleomorphic disease especially concerning its outcome
and prognosis [2]. In SLE patients NFC studies have described
many different capillary forms and patterns and a variable prev-
alence of capillary abnormalities has been reported [4]. How-
ever, sensitivity of the capillaroscopic method is lower in SLE
patients in respect to the so-called scleroderma-related diseases,
but it can provide a valid support for the diagnosis [5]. The typ-
ical capillaroscopic pattern in SLE (SLE pattern) consists basi-
cally of increased capillary tortuosity, which may affect the
three branches of the capillary loop, with changes like meander-
ing, corkscrew or circumvolutions and lengthening of loops,
which at times resemble glomeruloid structures [6].
NFC can be useful in the diagnostic procedure of the dis-
ease and lead to more effective strategies in the treatment of
systemic organ dysfunction in SLE and abnormalities in nail-
fold capillaroscopy may reﬂect the extent of microvascular
involvement in SLE. They also reported that all SLE patients
with internal organ manifestations showed severe or moderate
pathological changes under NFC [7].
This study aimed to investigate the pattern of NFC changes
in patients with SLE and correlate it with various clinical and
laboratory data.
2. Patients and methods
Forty patients with SLE attending the Rheumatology and
Rehabilitation department, Cairo University Hospital were se-
lected. All patients fulﬁlled the 1997 American College of
Rheumatology criteria for SLE [8]. Twenty age and sex
matched apparently healthy subjects were served as a control.
SLE patients who had associated diabetes mellitus or second-
ary antiphospholipid syndrome were excluded, as both of these
conditions can cause microangiopathic changes that could be
detected in NFC and affect the study results.
All patients were subjected to the following:
1. Full history taking including onset, course, duration of
the disease and manifestations of various systems
affections.2. Thorough clinical examination with special emphasis
on skin manifestations suggesting vasculitis.
3. Laboratory investigations included complete blood
count (CBC), erythrocyte sedimentation rate (ESR),
complete urine analysis, total 24 h urinary proteins,
kidney and liver function tests, antinuclear antibodies
(ANA), anti-DNA and quantitative determination of
serum complement levels (C3, C4).
4. Assessment of disease activity was done using the SLE
Disease Activity Index (SLEDAI) [9].
5. Assessment of the capillary circulation was done using
the nailfold capilloroscopy.
2.1. Nailfold capilloroscopy examination
Nailfold capillaroscopy was done using a dynamic capillaro-
scope (K.K. England) consisting of a light source, green ﬁlter,
dimming control, charge coupled device camera connected to a
frame grabber and a PC with a software dedicated to calibrate
and measure linear dimensions and areas.
Nailfold capillaroscopy examination was done to all pa-
tients and controls, where all subjects were examined in the sit-
ting position with the hand at the level of the heart. Each
patient was acclimatized for 15 min at a room temperature
of 20–24 C prior to NFC.
The fourth and ﬁfth ﬁngers of each hand were examined,
due to the greater skin transparency in these ﬁngers and their
examination usually offers the best capillary visibility [10]. No
interfering substances on the surface of the skin. Fingers af-
fected by recent local trauma were not analyzed. The patient’s
forearm was placed on a ﬁrm support on the investigation ta-
ble to allow easy ﬁxation of the patient’s ﬁngers under the
microscope. The ﬁnger chosen for investigation was placed un-
der the microscope objective. A drop of parafﬁn oil was ap-
plied to the nailfold before recording to make the skin
transparent and improve resolution. Only capillaries in the dis-
tal row of the nailfold were analyzed and scored [2].
The following NFC parameters were considered:
(1) Capillary loop diameters (afferent and efferent loops
diameters): The average diameter of the arteriolar limb
is 15.0 ± 2.5 lm whilst the venular limb is slightly big-
ger at 16.7 ± 3.0 lm [11]. Enlarged capillaries were
deﬁned as those having four or more times the width
of normal neighbor loops in the three limbs, ascendant,
transition, and descendant [12].
Table 1 The clinical features in studied SLE patients.
Clinical feature (n/%)
1. Constitutional manifestations 29/72.5
Fever 26/65
Weight loss 10/25
Fatigue 23/57.5
2. Mucocutaneous manifestations 36/90
Malar rash 29/72.5
Photosensitivity 17/42.5
Oral ulcers 25/62.5
Alopecia 9/22.5
S.C. nodules 1/2.5
3. Musculoskeletal manifestations 37/92.5
Arthralgia 37/92.5
Arthritis 32/80
Myalgia 9/22.5
Myositis 1/2.5
4. Vascular manifestations 19/47.5
(A) Cutaneous vasculitis 15/37.5
Palpable purpura 2/5
Levido reticularis 3/7.5
Skin mottling 8/20
Vasculitic ulcers 2/5
Peripheral gangrene 2/5
(B) Raynaud’s phenomenon 13/32.5
5. Pulmonary manifestations 19/47.5
Pleurisy 19/47.5
Pleural eﬀusion 8/20
6. Cardiac manifestations 5/12.5
Nailfold capilloroscopy in systemic lupus erythematosus 63(2) Presence of morphological abnormalities: Nailfold capil-
laries in the healthy subject usually show a regular archi-
tecture, uniform shape, distribution and diameter, and
most of them show a hairpin or U shaped aspect [13].
The capillary morphology was classiﬁed as normal (reg-
ular distribution of hairpin-like capillaries) or abnormal
when there was >10% capillary dystrophies in the form
of tortuous capillaries, meandering capillaries, cork-
screw and bushy capillaries [4].
(3) Capillary hemorrhages which were evaluated near the dis-
tal row inferred that the occurrence of micropetechiae of
focal distribution was related to everyday microtrauma
that may occur in healthy individuals but the occurrence
of micropetechiae of diffuse distribution is pathological
[14]. Capillary hemorrhages were considered as abnormal
when they were >10%, according to Caspary et al. [4].
2.2. Statistical analysis
An IBM compatible PC was used to store and analyze the data
and to produce graphic presentation of important results. Cal-
culations were done by means of statistically software package
namely ‘‘SPSS 13’’ for Windows (SPSS, Chicago, IL, USA).
Results are expressed as mean ± SD. Comparisons were made
by the unpaired ‘‘t’’ test. Correlation between variables was
tested with Pearsons’ correlation analysis. Chi-square test
was used for qualitative data. Signiﬁcance of results was con-
sidered non-signiﬁcant if P value >0.05, signiﬁcant if P value
<0.05 and highly signiﬁcant if P value <0.01.Carditis 2/5
Pericardial eﬀusion 3/7.5
7. Renal involvement: Although 30 patients (75%)
had nephritis, renal biopsies were done for
17 patients (42.5%), and their results
were as follows (Fig. 3)
30/75.5
Grade 1: 0 patients
Grade 2: 3 patients (7.5%)
Grade 3: 6 patients (15%)
Grade 4: 3 patients (7.5%)
Grade 5: 5 patients (12.5%)
8. Neurological manifestations 9/22.5
Stroke 1/2.5
Seizures 5/12.5
Psychosis 6/15
Mood disturbance 7/17.5
Peripheral neuropathy 2/5
9. Haematological manifestations 30/75
Anemia 28/70
Leucopenia 11/27.5
Thrombocytopenia 7/17.5
Pancytopenia 7/17.5
10. Systemic hypertension 10/253. Results
This study included 40 patients with SLE, 37 patients were
females and 3 were males. Their ages ranged from 16 to 47 years
with a mean age of 27.29 ± 8.02. Their age of disease onset ran-
ged from 9 to 43 years with a mean age of 22.375 ± 7.57. Their
disease duration ranged from 0.5 to 15 years with a mean of
4.987 ± 4.48 years. A group of 20 age/sex-matched control sub-
jects (M/F = 2/18). Their ages ranged from 16 to 40 with a
mean age of 26.6 ± 7.19 years, with no signs of connective tis-
sue disease or other vascular disorders, served as controls.
The clinical characteristics of the patients are shown in
Table 1.
3.1. Regarding drug consumption by this group of SLE patients
Thirty-eight patients (95%) were on oral corticosteroids during
the study period. The dose ranged from 5 to 45 mg/d. Thirty-
two patients (80%) were on antimalarials. The dose ranged
from 200 to 400 mg/d. Twenty-four patients (60%) were on
azathioprine. The dose ranged from 50 to 150 mg/d. Thirteen
patients (32.5%) received pulses of cyclophosphamide intrave-
nously. The dose ranged from 750 to 1000 mg monthly. Two
patients (5%) were on mycophenolate mofetil 1000 mg/d.
Laboratory ﬁndings in studied SLE patients were as
follows:
 H.B. % (ranged from 6.6 to 16.8 with a mean of 11.13 ±
2.16).
– 23 patients (57.5%) had anemia (hemoglobin <12 g/dl). TLC (ranged from 2.8 to 22 with a mean of 6.72 ± 3.36).
– 2 patients (5%) had leucopenia (white blood cells
<3500 mm2). PLT (ranged from 27 to 689 with a mean of 329.77 ±
133.14).
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<150,000 mm2). ALT (ranged from 4 to 75 with a mean of 20.55 ± 13.19).
 AST (ranged from 8 to 67 with a mean of 18.55 ± 10.23).
 Creatinine (ranged from 0.3 to 1.5 with a mean of
0.71 ± 0.27).
 24 h urinary proteins (ranged from 0 to 7.7 with a mean of
1.22 ± 1.75).
 C3 (ranged from 0.2 to 1.7 with a mean of 0.8 ± 0.34).
 C4 (ranged from 0.02 to 0.4 with a mean of 0.15 ± 0.1).
 ANA:
– 39 patients (97.5%) have +ve ANA. Anti-DNA:
– 30 patients (75%) have +ve anti-DNA.
SLEDI activity score (done at study time) ranged from 0 to
27 with a mean of 8.85 ± 6.21. Patients were classiﬁed accord-
ing to this score into 29 patients (72.5%) with mild activity, 9
patients (22.5%) with moderate activity and 2 patients (5%)
with severe activity.
Abnormal capilloroscopic patterns were found in the con-
trol group (3/20 had abnormal capillary forms, 1 had meander-
ing capillaries and 2 had tortuous capillaries). However, these
capillaroscopic abnormalities were not found in more than
10% of the total number of capillaries. The capillaroscopic
abnormalities were found more frequently in studied SLE pa-
tients than in the control group and the difference between the
two groups reached a statistical signiﬁcant value (P< 0.05).
The prevalence of SLE patients that have capillaroscopic
abnormalities was 30/40 patients (75%) as shown in Fig. 1.
Some SLE patients with NFC abnormalities have a single
type of capillaroscopic abnormalities. However, in the others,
two or more abnormal capillaroscopic patterns were found. In
SLE patients, 11/40 patients (27.5%) showed relevant capilla-
roscopic changes (capillaroscopic score >1).
In the control group, the mean of their capillary loop affer-
ent diameter was 8.2 ± 1.9 lm and the mean capillary loopure 1 Prevalence of capillaroscopic abnormalities in SLE
tients.
able 2 A comparison between SLE patients and controls as regar
eature SLE patients (lm)
apillary loop aﬀerent diameter 10.5 ± 3.7
apillary loop eﬀerent diameter 13.9 ± 4.9efferent diameter was 10.3 ± 1.3 lm. However, in SLE pa-
tients, the mean of their capillary loop afferent diameter was
10.5 ± 3.7 lm and the mean capillary loop efferent diameter
was 13.9 ± 4.9 lm. The difference between the two groups
regarding the afferent and efferent capillary loop diameters
reach statistical signiﬁcant P< 0.05 (Table 2).
The abnormal capillaroscopic patterns in the patients were
as follows: 18 patients (45%) were found to have tortuous cap-
illaries, 20 patients (50%) had meandering capillaries, 6 pa-
tients (15%) had corkscrew capillaries, 3 patients (7.5%) had
bushy capillaries, 9 patients (22.5%) had capillary enlargement
and 4 patients (10%) had capillary hemorrhage (Figs. 2 and 3).
Different capilloroscopic abnormalities were found to be
correlated to various demographic, clinical and laboratory
data. The capillary loop afferent diameter was found to be cor-
related with the disease duration, gangrene and capillary loop
efferent diameter (Table 3). The capillary loop efferent diame-
ter was found to be correlated with the disease duration, gan-
grene, capillary loop afferent diameter and cyclophosphamide
intake (Table 4). Negative correlation was found to be present
between the meandering capillaries morphology and the 24 h
urinary protein level. The presence of meandering capillaries
was also found to be correlated with the SLEDAI disease
activity score (Table 5).
The presence of corkscrew shaped capillaries was found to
be signiﬁcantly correlated with the disease duration and ESR
(Table 6).
Regarding other types of abnormal capillary patterns (tor-
tuous capillaries, bushy appearance and capillary hemorrhage,
no correlations were found with different demographic, clini-
cal and laboratory data.
4. Discussion
Although the sensitivity of the capillaroscopic method is lower
in SLE patients in respect to the so-called scleroderma-related
diseases, it can provide a valid support for the diagnosis [15].
This work aimed to study the prevalence of nailfold capil-
laroscopy changes in patients with SLE, ﬁnd out the patternsds mean ± SD of capillary loop diameters.
Controls (lm) P value Signiﬁcance
8.2 ± 1.9 <0.05 Signiﬁcant
10.3 ± 1.3 <0.05 Signiﬁcant
Figure 2 The abnormal capilloroscopic patterns in the patients.
Figure 3 (a) Tortuous capillaries; (b) meandering capillaries; (c) corkscrew capillaries; (d) bushy capillaries; (e) capillary enlargement; (f)
capillary hemorrhage.
Table 3 The statistical signiﬁcant relations with the capillary
loop afferent diameter.
Feature r P value Signiﬁcance
Disease duration 0.11 0.011 Signiﬁcant
Gangrene 7.56 0.000 Highly signiﬁcant
Capillary loop eﬀerent diameter 0.47 0.000 Highly signiﬁcant
Table 4 The statistical signiﬁcant relations with the capillary
loop efferent diameter.
Feature Type P value Signiﬁcance
Disease duration 0.19 0.019 Signiﬁcant
Gangrene 6.23 0.009 Highly signiﬁcant
Capillary loop aﬀerent
diameter
0.47 0.000 Highly signiﬁcant
Cyclophosphamide 2.05 0.044 Signiﬁcant
Nailfold capilloroscopy in systemic lupus erythematosus 65of these changes and to correlate these ﬁndings with different
clinical and laboratory parameters.
In our study, the prevalence of patients with capillaroscopic
abnormalities was 30/40 patients (75%). Some capilloroscopic
changes were found in the control group but the abnormalitieswere found more frequently through the patient group. The
difference between both groups reached a statistical signiﬁcant
value. Abd El Akher [16] found similar results.
Table 5 The statistical signiﬁcant relations with the presence
of meandering capillaries.
Feature Type P value Signiﬁcance
24 h urinary proteins 1.76 0.016 Signiﬁcant
SLEDAI score 2.01 0.031 Signiﬁcant
Table 6 The statistical signiﬁcant relations with the presence
of corkscrew shaped capillaries.
Feature Type P value Signiﬁcance
Disease duration 0.35 0.036 Signiﬁcant
ESR 1.29 0.027 Signiﬁcant
66 O. Ragab et al.Facina et al. [17] reported the prevalence of SLE patients
having capillaroscopic abnormalities to be 76.7%. Our results
are nearly similar. Both studies were conducted on Egyptian
population with a quite similar mean age as it was
27.29 ± 8.02 years in this study versus 26.11 ± 11.56 years in
her study. Kuryliszyn-Moskal et al. [18] reported the preva-
lence of nailfold capillary abnormalities to be 95.5% in their
SLE patients. The difference between their results and ours
may be due to the difference in the disease duration, as their
group of patients had longer disease duration which was
8.1 ± 7.8 years versus 4.987 ± 4.48 years in our study.
In our study, the morphological abnormalities varied be-
tween meandering capillaries, tortuous capillaries, corkscrew
capillaries, bushy capillaries, and capillary hemorrhage. The
meandering capillaries were found to be the most prevalent
type of abnormalities in 50% of the patients. Nearly similar re-
sults were found by others [18], who reported in their study on
SLE patients meandering capillaries in 60.6% of the patients.
Nagy and Czirjak [18] chose the meandering capillary pat-
tern as a predictive variable for SLE in patients having the
manifestations of connective tissue disease. Meandering capil-
lary pattern which is the commonest usually found in SLE pa-
tients may provide a support for diagnosis of SLE as does the
megacapillaries pattern in scleroderma [19].
We also found a statistically signiﬁcant positive correlation
(P< 0.05) between presence of meandering capillaries and
24 h urinary proteins. This could be due to the same pathology
affecting blood vessels in both nailfold region and the kidney.
Kabasakal et al. [20] reported that vascular lesions are com-
mon in lupus nephritis and may contribute signiﬁcantly to
overall disease severity, activity, and chronicity.
We found a statistical signiﬁcant positive correlation
(P< 0.05) between the presence of meandering capillaries
and Systemic Lupus Erythematosus Disease Activity Index
(SLEDI) score. The presence of meandering capillaries in
NFC examination may suggest that these patients could be
more prone to have active disease; although the exact data
are difﬁcult to obtain in a retrospective study.
In our study, tortuous capillaries were less frequent rather
than meandering capillaries in the SLE group. Similar results
were reported by others [21]. They were found in 45% of
SLE patients. However, Riccieri et al. [2], found tortuous cap-
illaries in only 16% of SLE patients. This difference between
their results and ours may be due to different ethnic groups be-
tween the studies.Regarding corkscrew capillaries, they were found in 15% of
our patients. Quite similar results were reported by Nagy and
Czirjak [18], who found corkscrew capillaries in 21.2% of SLE
patients.
Regarding enlarged capillaries, they were found in 22.5%
of our patients. Quite similar results were found by Nagy
and Czirjak [18], who reported that enlarged capillaries were
found in 24.2% of patients.
We found a statistically signiﬁcant positive (P< 0.05) cor-
relation between treatment with cyclophosphamide and capil-
lary enlargement. However, we could not found any reference
that capillary enlargement is considered one of the side effects
of cyclophosphamide. The presence of capillary enlargement
may be an evidence of severe disease that necessitate the use
of cyclophosphamide.
We concluded that patients with SLE had abnormal NFC
changes that are more prevalent than in the control. Different
abnormalities are found with the meandering capillaries the
most frequent pattern to occur. Enlargement of the capillary
loops found in NFC examination is correlated with the disease
duration and gangrene occurrence. Duration of SLE disease
may have an impact on microcirculation of these patients.
The presence of some nailfold capillaroscopy changes in SLE
patients may be an alarming sign to fatal ischemia of the digits.
Disease duration is also correlated with the presence of cork-
screw pattern. The presence of some nailfold capillaroscopy
changes in SLE patients may suggest that these patients could
be more prone to have active disease. Some abnormal patterns
are correlated with parameters of active disease. Meandering
capillaries are correlated with SLEDAI activity score and the
corkscrew pattern is correlated with the ESR. The meandering
capillary pattern correlated with 24 h urinary proteins (may be
indicator of renal affection). The pathology affecting blood ves-
sels in both nailfold region and the kidney could be the same.
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